Source: Pharmaceutical Processing World

PCI Pharma Services: PCI Pharma Services makes $365M investment in drug delivery device manufacturing

PCI Pharma Services announced that it's investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. PCI Pharma plans to put its investment toward new and...The post PCI Pharma Services makes $365M investment in drug delivery device manufacturing appeared first on Pharmaceutical Processing World.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Salim Haffar's photo - CEO of PCI Pharma Services

CEO

Salim Haffar

CEO Approval Rating

- -/100

Read more